Journal
CHEMISTRY & BIOLOGY
Volume 11, Issue 3, Pages 301-307Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2004.03.003
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI47003-03, 7 R01 AI47003-04] Funding Source: Medline
Ask authors/readers for more resources
Magnetic resonance imaging (MRI) is a powerful tool for acquiring images of opaque living animals with the benefit of tracking events over extended periods of time on the same specimen. Contrast agents are used to enhance regions, tissues, and cells that are magnetically similar but histologically distinct. A principal barrier to the development of MRI contrast agents for investigating biological questions is the delivery of agents across cellular membranes. Here, we describe the synthesis and in vitro testing of Gd(III)-based MRI contrast agents containing varying length polyarginine oligomers capable of permeating cell membranes. We examine the effect of the length of oligomer on T-1 enhancement and cellular uptake. Furthermore, the effect of incubation time, concentration, and cell type on uptake is explored. Toxicity and washout studies are performed in addition to MRI phantom studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available